Age‑dependent loss of Piezo2‑mediated mechanosensitivity in enterochromaffin cells drives serotonergic hypofunction, slowed colonic transit, and microbiome dysbiosis
With advancing age, enterochromaffin (EC) cells exhibit a selective decline in Piezo2 channel expression or function, blunting mechanotransduction‑triggered calcium influx and subsequent TPH1‑dependent serotonin release. This mechanosensory deficit reduces luminal‑stimulus‑evoked 5‑HT secretion, impairing activation of enteric 5‑HT3/4 receptors that promote propulsive motility. The resulting hypomotility fosters colonic stasis, which in turn reshapes the gut microbiome toward a dysbiotic state characterized by decreased short‑chain‑fatty‑acid producers and increased pathobionts. Restoring Piezo2 activity in aged EC cells should rescue serotonin release, normalize transit, and mitigate age‑related microbiome alterations.
Mechanistic Rationale
- Mechanosensory gating of EC signaling – EC cells sense luminal stretch and shear stress primarily via Piezo2, which opens to permit Ca²⁺ entry, activating calmodulin‑dependent kinases that phosphorylate TPH1 and boost 5‑HT synthesis【1](https://pubmed.ncbi.nlm.nih.gov/40812684/)】.
- Age‑related epigenetic silencing – In aging intestinal epithelium, increased DNA methylation at the Piezo2 promoter (observed in aged colon crypts) suppresses transcription, a pattern mirrored in other mechanosensors like Piezo1 in vascular endothelium【2](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.837166/full)】.
- Consequences for serotonin dynamics – Reduced Piezo2‑mediated Ca²⁺ spikes lower vesicular 5‑HT exocytosis, diminishing paracrine activation of submucosal 5‑HT3R/4R neurons that coordinate peristaltic reflexes. Chronic low 5‑HT tone is linked to slowed transit and constipation phenotypes prevalent in the elderly【3](https://onlinelibrary.wiley.com/doi/10.1111/nmo.13869)】.
- Feedback to microbiome – Stagnant luminal contents favor fermentative over saccharolytic microbes, altering SCFA production; SCFAs normally stimulate EC receptors (FFAR2/3) to augment serotonin release, creating a vicious cycle of mechanosensory and metabolite‑driven hypo‑signaling.
Predictions & Experimental Design
- Prediction 1: Aged mice (≥24 mo) will show ↓Piezo2 mRNA and protein in isolated EC cells (sorted via tdTomato‑TPH1 reporter) compared with young (3 mo) counterparts.
- Prediction 2: Mechanical stretch of colonic segments from aged mice will elicit smaller Ca²⁺ transients (GCaMP6s imaging) and lower 5‑HT release (ELISA) than those from young mice; exogenous Piezo2 agonist (Yoda1) will rescue the response in aged tissue.
- Prediction 3: EC‑specific Piezo2 overexpression (via Villin‑Cre‑ERT2‑driven AAV) in aged mice will normalize serotonin release, increase colonic transit time (carmine red assay), and shift microbiome composition toward higher Lactobacillus/Bifidobacterium relative abundance (16S rRNA sequencing).
- Prediction 4: Pharmacological inhibition of Piezo2 in young mice will phenocopy the aged EC hyporesponsive state, confirming causality.
Potential Implications
If validated, this hypothesis identifies EC mechanosensitivity as a upstream, reversible node linking intestinal aging to motility disorders and dysbiosis. It suggests therapeutic avenues—such as targeted Piezo2 activation, epigenetic drugs that demethylate the Piezo2 promoter, or EC‑specific gene‑replacement strategies—to ameliorate age‑related constipation and improve microbiome health without broadly altering systemic serotonin levels.